Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer
- 22 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 104 (11) , 1568-1577
Abstract
Despite improvements in diagnostic imaging and staging, unresectable pancreatic cancer is still encountered during surgical exploration with curative intent. This nationwide study investigated outcomes in patients with unresectable pancreatic cancer found during surgical exploration. All patients diagnosed with primary pancreatic (adeno)carcinoma (2009–2013) in the Netherlands Cancer Registry were included. Predictors of unresectability, 30-day mortality and poor survival were evaluated using logistic and Cox proportional hazards regression analysis. There were 10 595 patients with pancreatic cancer during the study interval. The proportion of patients undergoing surgical exploration increased from 19·9 to 27·0 per cent (P < 0·001). Among 2356 patients who underwent surgical exploration, the proportion of patients with tumour resection increased from 61·6 per cent in 2009 to 71·3 per cent in 2013 (P < 0·001), whereas the contribution of M1 disease (18·5 per cent overall) remained stable. Patients who had exploration only had an increased 30-day mortality rate compared with those who underwent tumour resection (7·8 versus 3·8 per cent; P < 0·001). In the non-resected group, among those with M0 (383 patients) and M1 (435) disease at surgical exploration, the 30-day mortality rate was 4·7 and 10·6 per cent (P = 0·002), median survival was 7·2 and 4·4 months (P < 0·001), and 1-year survival rates were 28·0 and 12·9 per cent, respectively. Among other factors, low hospital volume (0–20 resections per year) was an independent predictor for not undergoing tumour resection, but also for 30-day mortality and poor survival among patients without tumour resection. Exploration and resection rates increased, but one-third of patients who had surgical exploration for pancreatic cancer did not undergo resection. Non-resectional surgery doubled the 30-day mortality rate compared with that in patients undergoing tumour resection.Keywords
This publication has 36 references indexed in Scilit:
- Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancerWorld Journal of Surgical Oncology, 2012
- Palliative Surgical Management of Patients with Unresectable Pancreatic Adenocarcinoma: Trends and Lessons Learned from a Large, Single Institution ExperienceJournal of Gastrointestinal Surgery, 2011
- Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic headEuropean Journal of Surgical Oncology, 2011
- Systematic review and meta-analysis of the volume–outcome relationship in pancreatic surgeryBritish Journal of Surgery, 2011
- A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic statusBritish Journal of Cancer, 2010
- Preoperative evaluation of pancreatic adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Palliative biliary stents for obstructing pancreatic carcinoma2006
- Hospital Volume and Mortality After Pancreatic ResectionAnnals of Surgery, 2005
- Laparoscopic Staging and Subsequent Palliation in Patients With Peripancreatic CarcinomaAnnals of Surgery, 2003
- Hospital Volume and Surgical Mortality in the United StatesNew England Journal of Medicine, 2002